Phase 1b Study of Pembrolizumab in Patients with Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Results from the Ongoing Keynote-013 Trial
- Resource Type
- Journal
- Source
BLOOD ; DEC 2 2016, 128 22, 6p.- Subject
- Language
- English
- ISSN
- 15280020